StockMarketWire.com - Circassia Pharmaceuticals (LSE: CIR), a specialty biopharmaceutical company focused on allergy, has appointed Lota S Zoth as a non-executive director.

Ms Zoth has significant financial experience gained in a number of global public companies. Most recently she was CFO at MedImmune, and previously held senior positions at PSINet, Sodexho Marriott, PepsiCo and Ernst & Young.


At 10:37am: [LON:CIR] Circassia Pharmaceuticals Plc Ord 0.08p share price was +3.13p at 253.13p



Story provided by StockMarketWire.com